Ionis Pharmaceuticals, Inc. (IONS) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

15/25

Growth 4 Margin 2 Expansion 5 Platform 1 Financial 3

latest quarter score

Earnings Reports

15
Ionis (IONS) Q2 2026: Commercial Revenue Jumps 15% as Tringolza SHTG Launch Expands Market Reach
July 29, 2026
16
IONIS (IONS) Q1 2026: Olazarsen Peak Sales Raised 50% to $3B, Anchoring Commercial Expansion
April 29, 2026
14
IONIS (IONS) Q4 2025: Olazarsen Peak Revenue Raised Above $2B as Launch Readiness Accelerates
February 25, 2026
17
Ionis (IONS) Q3 2025: Tringolza Sales Jump 70% as Blockbuster Launches Take Shape
October 29, 2025
15
Ionis (IONS) Q2 2025: Tringolza Triples Sales, Sets Stage for 3 Launches and $100M Guidance Hike
July 30, 2025
21
Ionis (IONS) Q1 2025: Revenue Guidance Raised 20% as Tringolza Launch Exceeds Early Expectations
July 04, 2025

Browse all companies